# The Impact of Air Pollution and Obesity on Cognitive Decline and Risk of Alzheimer’s Disease

**Authors:** Zoe A. Keller, Katherine M. Eggers, Joshua P. Nixon, Tammy A. Butterick

PMC · DOI: 10.3390/ijms27010092 · International Journal of Molecular Sciences · 2025-12-21

## TL;DR

This paper explores how obesity and air pollution together increase Alzheimer’s risk by disrupting brain health through shared biological pathways.

## Contribution

The paper introduces a novel mechanistic framework linking obesity and air pollution to Alzheimer’s via Wnt/β-catenin signaling suppression.

## Key findings

- Obesity and air pollution synergistically impair brain metabolism and accelerate cognitive decline.
- Wnt/β-catenin signaling suppression is linked to Alzheimer’s pathology like amyloid accumulation and tau hyperphosphorylation.
- The Wnt pathway is proposed as a potential therapeutic target for neuroprotection in at-risk populations.

## Abstract

Obesity and air pollution are two pervasive and increasingly prevalent risk factors for neurodegenerative diseases, like Alzheimer’s disease. Both independently disrupt brain homeostasis through overlapping mechanisms, including chronic neuroinflammation, oxidative stress, and insulin resistance. Recent evidence highlights the Wnt/β-catenin signaling pathway as a critical integrator of these insults, mediating neuroprotective processes such as synaptic plasticity, blood–brain barrier integrity, and neuronal survival. In this review, we synthesize emerging data on how obesity-driven metabolic dysfunction and air pollution-induced oxidative injury synergize to impair brain metabolism and accelerate cognitive decline. We describe the roles of pathways such as JAK-STAT, NF-κB, and TLR4 signaling cascades, as well as leptin and adiponectin imbalances, in modulating glial reactivity and neuroimmune signaling. Particular attention is given to the suppression of Wnt/β-catenin signaling in obese and pollution-exposed brains, and its consequences for Alzheimer’s disease pathology, including β-amyloid accumulation and tau hyperphosphorylation. Finally, we examine the translational implications, highlighting the Wnt pathway as a potential therapeutic target that offers neuroprotection in the context of dual metabolic and environmental stress. Together, these insights provide a mechanistic framework that links systemic dysfunction to central nervous system vulnerability, offering pathways for intervention in at-risk populations.

## Linked entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], TLR4 (toll like receptor 4) [NCBI Gene 7099]
- **Diseases:** Alzheimer’s disease (MONDO:0004975), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}
- **Diseases:** insulin resistance (MESH:D007333), Obesity (MESH:D009765), Cognitive Decline (MESH:D003072), metabolic dysfunction (MESH:D008659), Alzheimer's Disease (MESH:D000544), neuroinflammation (MESH:D000090862), neurodegenerative diseases (MESH:D019636)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12785463/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12785463/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12785463/full.md

---
Source: https://tomesphere.com/paper/PMC12785463